Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aehr Test Systems (AEHR) vs InMode Ltd (INMD) Price & Performance

Aehr Test SystemsTrade
InMode LtdTrade

Price performance (Past 24H)

Key statistics

Aehr Test Systems vs InMode Ltd — how do they compare? Aehr Test Systems trades at $129.23 (market cap $3.82B), while InMode Ltd trades at $15.25 (market cap $872.08M). The key difference: Aehr Test Systems is far larger — about 4.4× InMode Ltd's market cap, and Aehr Test Systems is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.

AEHRINMD
Market Cap
$3.82B$872.08M
Sector
TechnologyTechnology
52-Week High
$117.18$16.62
52-Week Low
$17.38$12.76
Enterprise Value
$3.72B$375.42M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aehr Test Systems

Aehr Test Systems (AEHR) trades at $129.23, up 21.69% in the last 24 hours, reflecting strong momentum. The stock is technically bullish, trading near resistance at $129, with a high RSI suggesting potential overbought conditions. Fundamentally, the company reported a net loss of $3.91 million for 2025, but has beaten EPS estimates for three consecutive quarters. Recent news highlights a $22 million follow-on order for AI processor wafer-level burn-in systems, signaling robust demand in high-growth sectors.

The outlook is supported by record bookings and a strategic pivot to AI infrastructure, though high valuation multiples and insider selling pose risks. Revenue growth guidance of 160-200% for FY27 offers significant upside potential, but investor caution is warranted due to customer concentration and current unprofitability.

InMode Ltd

INMD trades at $15.23, up 0.26% today, with a neutral technical outlook and mixed earnings history including a Q1 2026 miss. The company reported Q2 2026 revenue of $95.6 million, consistent year-over-year, and maintains a strong gross profit margin of 76.52%. Recent news highlights an unsolicited acquisition offer from Steel Partners at $16.75 per share and shareholder activism urging rejection, creating uncertainty around corporate governance.

The stock presents a value opportunity with low P/E and EV/EBITDA ratios, but risks include earnings volatility, potential acquisition fallout, and ongoing securities fraud investigations. Analyst consensus is divided between Buy and Hold ratings, reflecting cautious optimism amid near-term headwinds. Long-term growth depends on execution of international expansion and innovation in medical technologies.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aehr Test Systems

Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.

Read more on AEHR

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

Read more on INMD